Hereditary 1,25-dihydroxyvitamin-d-resistant rickets

Vitamin D

Volumn , Issue , 2011, Pages 1197-1232

  Malloy, Peter J ^a   Tiosano, Dov ^b   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054979487     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10065-4     Document Type: Chapter

References (221)

1. 3 in normal physiology. Mol. Cell Endocrinol. 1990, 72:C57-62.
2. 3 receptor. J. Recept. Res. 1991, 11:699-716.
3. Malloy P.J., Pike J.W., Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 1999, 20:156-188.
4. Feldman D., Malloy P.J., Krishnan A.V., Balint E. Vitamin D: biology, action, and clinical implications. Osteoporosis 2007, 317-382. Academic Press, San Diego. third ed. R. Marcus, D. Feldman, D.A. Nelson, C.J. Rosen (Eds.).
5. Malloy P.J., Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Dev. 2003, 6:175-199.
6. Malloy P.J., Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol. Metab. Clin. N. Am. 2010, 39:333-346.
7. Albright F., Butler A.M., Bloomberg E. Rickets resistant to vitamin D therapy. Am. J. Dis. Child. 1937, 54:531-547.
8. Prader V.A., Illig R., Heierli E. Eine besondere form der primaren vitamin-D-resistenten rachitis mit hypocalcamie und autosomal-dominantem erbgang: die hereditare pseudo-mangelrachitis. Helvetica Paediatrica Acta 1961, 16:452-468.
9. 3 1alpha-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
10. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 1997, 11:1961-1970.
11. 3 1(alpha)-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Engl. J. Med. 1998, 338:653-661.
12. Brooks M.H., Bell N.H., Love L., Stern P.H., Orfei E., Queener S.F., et al. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N. Engl. J. Med. 1978, 298:996-999.
13. Marx S.J., Spiegel A.M., Brown E.M., Gardner D.G., Downs R.W., Attie M., et al. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 1978, 47:1303-1310.
14. Tiosano D., Weisman Y., Hochberg Z. The role of the vitamin D receptor in regulating vitamin D metabolism: a study of vitamin D-dependent rickets, type II. J. Clin. Endocrinol. Metab. 2001, 86:1908-1912.
15. Angeli A., Dovio A. The hungry bone: expected and unexpected. Ann. Ital. Med. Int. 2004, 19:IV-VI.
16. Farese S. [The hungry bone syndrome - an update]. Ther. Umsch. 2007, 64:277-280.
17. Rosen J.F., Fleischman A.R., Finberg L., Hamstra A., DeLuca H.F. Rickets with alopecia: an inborn error of vitamin D metabolism. J. Pediatr. 1979, 94:729-735.
18. Liberman U.A., Samuel R., Halabe A., Kauli R., Edelstein S., Weisman Y., et al. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 1980, 1:504-506.
19. 3. J. Pediatr. 1980, 96:701-703.
20. Kudoh T., Kumagai T., Uetsuji N., Tsugawa S., Oyanagi K., Chiba Y., et al. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D. Eur. J. Pediatr. 1981, 137:307-311.
21. Balsan S., Garabedian M., Liberman U.A., Eil C., Bourdeau A., Guillozo H., et al. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. J. Clin. Endocrinol. Metab. 1983, 57:803-811.
22. Laufer D., Benderly A., Hochberg Z. Dental pathology in calcitirol resistant rickets. J. Oral Med. 1987, 42:272-275.
23. Bliziotes M., Yergey A.L., Nanes M.S., Muenzer J., Begley M.G., Viera N.E., et al. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. J. Clin. Endocrinol. Metab. 1988, 66:294-300.
24. 3 in a patient without alopecia. Eur. J. Pediatr. 1986, 145:389-395.
25. Beer S., Tieder M., Kohelet D., Liberman O.A., Vure E., Bar-Joseph G., et al. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol. 1981, 14:395-402.
26. 3. J. Clin. Endocrinol. Metab. 1982, 55:1020-1022.
27. Hochberg Z., Benderli A., Levy J., Vardi P., Weisman Y., Chen T., et al. 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia. Am. J. Med. 1984, 77:805-811.
28. Hirst M.A., Hochman H.I., Feldman D. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J. Clin. Endocrinol. Metab. 1985, 60:490-495.
29. 3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics 1987, 80:97-101.
30. Yagi H., Ozono K., Miyake H., Nagashima K., Kuroume T., Pike J.W. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J. Clin. Endocrinol. Metab. 1993, 76:509-512.
31. Malloy P.J., Weisman Y., Feldman D. Hereditary 1 alpha,25-dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J. Clin. Endocrinol. Metab. 1994, 78:313-316.
32. 3 resistant rickets in seven related families. J. Clin. Invest. 1990, 86:2071-2079.
33. Heaney R.P. Vitamin D: role in the calcium economy. Vitamin D 1997, 485-497. Academic Press, San Diego. D. Feldman, F. Glorieux, J.W. Pike (Eds.).
34. Heaney R.P., Barger-Lux M.J., Dowell M.S., Chen T.C., Holick M.F. Calcium absorptive effects of vitamin D and its major metabolites. J. Clin. Endocrinol. Metab. 1997, 82:4111-4116.
35. Hochberg Z., Gilhar A., Haim S., Friedman-Birnbaum R., Levy J., Benderly A. Calcitriol-resistant rickets with alopecia. Arch. Dermatol. 1985, 121:646-647.
36. Marx S.J., Bliziotes M.M., Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol. 1986, 25:373-381.
37. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979, 206:1188-1190.
38. Berger U., Wilson P., McClelland R.A., Colston K., Haussler M.R., Pike J.W., et al. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J. Clin. Endocrinol. Metab. 1988, 67:607-613.
39. Bergman R., Schein-Goldshmid R., Hochberg Z., Ben-Izhak O., Sprecher E. The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study. Arch. Dermatol. 2005, 141:343-351.
40. Miller J., Djabali K., Chen T., Liu Y., Ioffreda M., Lyle S., et al. Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene. J. Invest. Dermatol. 2001, 117:612-617.
41. Malloy P.J., Xu R., Peng L., Clark P.A., Feldman D. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol. Endocrinol. 2002, 16:2538-2546.
42. Skorija K., Cox M., Sisk J.M., Dowd D.R., MacDonald P.N., Thompson C.C., et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol. Endocrinol. 2005, 19:855-862.
43. Reichel H., Koeffler H.P., Norman A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989, 320:980-991.
44. 3 receptors: structure and function in transcription. Ann. Rev. Nutr. 1991, 11:189-216.
45. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocrine. Rev. 1992, 13:719-764.
46. Bikle D.D. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocrine. Rev. 1992, 13:765-784.
47. Darwish H., DeLuca H.F. Vitamin D-regulated gene expression. Crit. Rev. Eukaryot. Gene Expr. 1993, 3:89-116.
48. MacDonald P.N., Dowd D.R., Haussler M.R. New insight into the structure and functions of the vitamin D receptor. Semin. Nephrol. 1994, 14:101-118.
49. Feldman D., Malloy P.J., Gross C. Vitamin D: biology, action, and clinical implications. Osteoporosis 2001, 257-303. Academic Press, San Diego. R. Marcus, D. Feldman, J. Kelsey (Eds.).
50. Hochberg Z., Borochowitz Z., Benderli A., Vardi P., Oren S., Spirer Z., et al. Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands?. J. Clin. Endocrinol. Metab. 1985, 60:57-61.
51. Even L., Weisman Y., Goldray D., Hochberg Z. Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets. J. Clin. Endocrinol. Metab. 1996, 81:2836-2840.
52. Manolagas S.C., Yu X.P., Girasole G., Bellido T. Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin. Nephrol. 1994, 14:129-143.
53. Etzioni A., Hochberg Z., Pollak S., Meshulam T., Zakut V., Tzehoval E., et al. Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin D. Pediatr. Res. 1989, 25:276-279.
54. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
55. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94:9831-9835.
56. Gross C., Eccleshall T.R., Malloy P.J., Villa M.L., Marcus R., Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J. Bone Miner. Res. 1996, 11:1850-1855.
57. Saijo T., Ito M., Takeda E., Huq A.H., Naito E., Yokota I., et al. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am. J. Hum. Genet. 1991, 49:668-673.
58. Crofts L.A., Hancock M.S., Morrison N.A., Eisman J.A. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc. Natl. Acad. Sci. USA 1998, 95:10529-10534.
59. Berg J.M. Proposed structure for the zinc-binding domains from transcription factor IIIA and related proteins. Proc. Natl. Acad. Sci. USA 1988, 85:99-102.
60. Mader S., Kumar V., de Verneuil H., Chambon P. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 1989, 338:271-274.
61. Umesono K., Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989, 57:1139-1146.
62. Hsieh J.C., Jurutka P.W., Selznick S.H., Reeder M.C., Haussler C.A., Whitfield G.K., et al. The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation. Biochem. Biophys. Res. Commun. 1995, 215:1-7.
63. Hsieh J.C., Shimizu Y., Minoshima S., Shimizu N., Haussler C.A., Jurutka P.W., et al. Novel nuclear localization signal between the two DNA-binding zinc fingers in the human vitamin D receptor. J. Cell Biochem. 1998, 70:94-109.
64. Shaffer P.L., Gewirth D.T. Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J. 2002, 21:2242-2252.
65. Shaffer P.L., Gewirth D.T. Structural analysis of RXR-VDR interactions on DR3 DNA. J. Steroid Biochem. Mol. Biol. 2004, 89-90:215-219.
66. Hsieh J.C., Whitfield G.K., Oza A.K., Dang H.T., Price J.N., Galligan M.A., et al. Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor. Biochemistry 1999, 38:16347-16358.
67. Shaffer P.L., McDonnell D.P., Gewirth D.T. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor. Biochemistry 2005, 44:2678-2685.
68. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 2000, 5:173-179.
69. Blanco J.C., Wang I.M., Tsai S.Y., Tsai M.J., O'Malley B.W., Jurutka P.W., et al. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl. Acad. Sci. USA 1995, 92:1535-1539.
70. MacDonald P.N., Sherman D.R., Dowd D.R., Jefcoat S.C., DeLisle R.K. The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem. 1995, 270:4748-4752.
71. DeLuca H.F., Zierold C. Mechanisms and functions of vitamin D. Nutr. Rev. 1998, 56:S4-S10. discussion S54-S75.
72. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J., Thompson P.D., Selznick S.H., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Min. Res. 1998, 13:325-349.
73. 3 receptor: a network of coactivator interactions. Gene. 2000, 246:9-21.
74. 3 receptors: gene regulation and genetic circuitry. FASEB J. 1988, 2:3043-3053.
75. Racz A., Barsony J. Hormone-dependent translocation of vitamin D receptors is linked to transactivation. J. Biol. Chem. 1999, 274:19352-19360.
76. Freedman L.P. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 1999, 97:5-8.
77. Chen T.L., Hirst M.A., Cone C.M., Hochberg Z., Tietze H.U., Feldman D. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. J. Clin. Endocrinol. Metab. 1984, 59:383-388.
78. 3. Proc. Natl. Acad. Sci. USA 1989, 86:4455-4459.
79. Morrison N.A., Shine J., Fragonas J.C., Verkest V., McMenemy M.L., Eisman J.A. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 1989, 246:1158-1161.
80. Ozono K., Liao J., Kerner S.A., Scott R.A., Pike J.W. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J. Biol. Chem. 1990, 265:21881-21888.
81. Lian J., Stewart C., Puchacz E., Mackowiak S., Shalhoub V., Collart D., et al. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc. Natl. Acad. Sci. USA 1989, 86:1143-1147.
82. 3. Proc. Natl. Acad. Sci. USA 1990, 87:369-373.
83. 3-mediated transcriptional activation. Mol. Endocrinol. 1991, 5:373-385.
84. 3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 1990, 87:9995-9999.
85. 3-response element in the 5'-flanking region of the rat calbindin D-9k gene. Proc. Natl. Acad. Sci. USA 1992, 89:603-607.
86. 3- and butyrate-inducible responses. Proc. Natl. Acad. Sci. USA 1993, 90:2984-2988.
87. 3 24-hydroxylase gene. J. Biol. Chem. 1994, 269:10545-10550.
88. 3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim. Biophys. Acta 1995, 1263:1-9.
89. Zierold C., Darwish H.M., DeLuca H.F. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J. Biol. Chem. 1995, 270:1675-1678.
90. Hughes M.R., Malloy P.J., Kieback D.G., Kesterson R.A., Pike J.W., Feldman D., et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988, 242:1702-1705.
91. 3-resistant rickets in three families. Proc. Natl. Acad. Sci. USA 1989, 86:9783-9787.
92. 3 in humans are transcriptionally inactive in vitro. J. Biol. Chem. 1989, 264:20230-20234.
93. Zerwekh J.E., Glass K., Jowsey J., Pak C.Y. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 1979, 49:171-175.
94. Colston K., Hirst M., Feldman D. Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology 1980, 107:1916-1922.
95. 3 receptors in human skin biopsies. J. Clin. Endocrinol. Metab. 1980, 51:1463-1465.
96. 3 in rat skin. Proc. Natl. Acad. Sci. USA 1980, 77:5822-5826.
97. Eil C., Liberman U.A., Rosen J.F., Marx S.J. A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N. Engl. J. Med. 1981, 304:1588-1591.
98. 3. J. Clin. Endocrinol. Metab. 1983, 56:824-830.
99. 3. J. Clin. Invest. 1983, 72:1190-1199.
100. 3: association with heterogeneous defects in cultured skin fibroblasts. J. Clin. Invest. 1983, 71:192-200.
101. Liberman U.A., Eil C., Holst P., Rosen J.F., Marx S.J. Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone. J. Clin. Endocrinol. Metab. 1983, 57:958-962.
102. Liberman U.A., Eil C., Marx S.J. Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation. J. Clin. Endocrinol. Metab. 1986, 62:122-126.
103. Malloy P.J., Hochberg Z., Pike J.W., Feldman D. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J. Clin. Endocrinol. Metab. 1989, 68:263-269.
104. 3 receptors. Science 1984, 224:879-881.
105. Dokoh S., Haussler M.R., Pike J.W. Development of a radioligand immunoassay for 1,25-dihydroxycholecalciferol receptors utilizing monoclonal antibody. Biochem. J. 1984, 221:129-136.
106. 3 receptor. Proc. Natl. Acad. Sci. USA 1982, 79:7719-7723.
107. 3. Generation by a preparation enriched in a 64,000-dalton protein. J. Biol. Chem. 1983, 258:1289-1296.
108. 3. Interaction and effects of binding on receptor function. J. Biol. Chem. 1984, 259:1167-1173.
109. 3 in cultured skin fibroblasts. J. Clin. Invest. 1985, 75:954-960.
110. Castells S., Greig F., Fusi M.A., Finberg L., Yasumura S., Liberman U.A., et al. Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. J. Clin. Endocrinol. Metab. 1986, 63:252-256.
111. 3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 1985, 76:2012-2015.
112. Takeda E., Kuroda Y., Saijo T., Toshima K., Naito E., Kobashi H., et al. Rapid diagnosis of vitamin D-dependent rickets type II by use of phytohemagglutinin-stimulated lymphocytes. Clin. Chim. Acta. 1986, 155:245-250.
113. 3 of cells from parents of patients with vitamin D-dependent rickets type II. J. Clin. Endocrinol. Metab. 1990, 70:1068-1074.
114. 3. Brit. J. Haematol. 1987, 67:267-271.
115. 3 receptor. Mol. Cell Endocrinol. 1990, 70:1-11.
116. Yenamandra S.P., Hellman U., Kempkes B., Darekar S.D., Petermann S., Sculley T., et al. Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol. Life Sci. 2010, 67:4249-4256.
117. 3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II. Acta Paediatr. Jpn. 1990, 32:39-43.
118. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 1988, 85:3294-3298.
119. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988, 239:487-491.
120. Refetoff S., Weiss R.E., Usala S.J. The syndromes of resistance to thyroid hormone. Endocrine. Rev. 1993, 14:348-399.
121. Olateju T.O., Vanderpump M.P. Thyroid hormone resistance. Ann. Clin. Biochem. 2006, 43:431-440.
122. Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M., French F.S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Rev. 1995, 16:271-321.
123. Galani A., Kitsiou-Tzeli S., Sofokleous C., Kanavakis E., Kalpini-Mavrou A. Androgen insensitivity syndrome: clinical features and molecular defects. Hormones (Athens) 2008, 7:217-229.
124. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331:1056-1061.
125. Werner S., Bronnegard M. Molecular basis of glucocorticoid-resistant syndromes. Steroids 1996, 61:216-221.
126. Charmandari E., Kino T., Chrousos G.P. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann. NY Acad. Sci. 2004, 1024:168-181.
127. Geller D.S., Rodriguez-Soriano J., Vallo Boado A., Schifter S., Bayer M., Chang S.S., et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat. Genet. 1998, 19:279-281.
128. Sartorato P., Khaldi Y., Lapeyraque A.L., Armanini D., Kuhnle U., Salomon R., et al. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Mol. Cell Endocrinol. 2004, 217:119-125.
129. 3. Mol. Endocrinol. 1990, 4:623-631.
130. Takeda E., Yokota I., Kawakami I., Hashimoto T., Kuroda Y., Arase S. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy. Eur. J. Pediatr. 1989, 149:54-57.
131. Yokota I., Takeda E., Ito M., Kobashi H., Saijo T., Kuroda Y. Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II. J. Inherit. Metab. Dis. 1991, 14:231-240.
132. Rut A.R., Hewison M., Kristjansson K., Luisi B., Hughes M.R., O'Riordan J.L. Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures. Clin. Endocrinol. 1994, 41:581-590.
133. Lin J.P., Uttley W.S. Intra-atrial calcium infusions, growth, and development in end organ resistance to vitamin D. Arch. Dis. Child 1993, 69:689-692.
134. Simonin G., Chabrol B., Moulene E., Bollini G., Strouc S., Mattei J.F., et al. Vitamin D-resistant rickets type II: apropos of 2 cases. Pediatrie 1992, 47:817-820.
135. Lin N.U.-T., Malloy P.J., Sakati N., Al-Ashwal A., Feldman D. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D resistant rickets. J. Clin. Endocrinol. Metab. 1996, 81:2564-2569.
136. Sakati N., Woodhouse N.J.Y., Niles N., Harfi H., de Grange D.A., Marx S. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy. Hormone Res. 1986, 24:280-287.
137. Shafeghati Y., Momenin N., Esfahani T., Reyniers E., Wuyts W. Vitamin D-dependent rickets type II: report of a novel mutation in the vitamin D receptor gene. Arch. Iran Med. 2008, 11:330-334.
138. Malloy P.J., Wang J., Srivastava T., Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor. Mol. Genet. Metab. 2010, 99:72-79.
139. Asunis I., Marini M.G., Porcu L., Meloni A., Cabriolu A.L., Cao A., et al. A novel missense mutation (C84R) in a patient with type II vitamin D-dependent rickets. Exp. Clin. Endocrinol. Diabetes 2010, 118:177-179.
140. Malloy P.J., Hughes M.R., Pike J.W., Feldman D. Vitamin D receptor mutations and hereditary 1,25-dihydroxyvitamin D resistant rickets. Vitamin D: gene regulation, structure-function analysis, and clinical application: eighth workshop on vitamin D 1991, 116-124. Walter de Gruyter, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
141. Wiese R.J., Goto H., Prahl J.M., Marx S.J., Thomas M., al-Aqeel A., et al. Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds. Mol. Cell Endocrinol. 1993, 90:197-201.
142. Cockerill F.J., Hawa N.S., Yousaf N., Hewison M., O'Riordan J.L., Farrow S.M. Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. J. Clin. Endocrinol. Metab. 1997, 82:3156-3160.
143. 3. J. Clin. Invest. 1993, 92:12-16.
144. 3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. J. Clin. Invest. 1989, 83:2093-2101.
145. Zhu W., Malloy P.J., Delvin E., Chabot G., Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor. J. Bone Miner. Res. 1998, 13:259-264.
146. 3-resistant rickets. J. Clin. Endocrinol. Metab. 1997, 82:3892-3894.
147. Bouillon R., Vainsel M. Resistance syndromes to calciotropic hormones. Rev. Franc. Endocrinol. Clin. 1990, 31:435-444.
148. Malloy P.J., Zhu W., Bouillon R., Feldman D. A novel nonsense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol. Genet. Metab. 2002, 77:314-318.
149. N. Forghani, C. Lum, S. Krishnan, J. Wang, D.M. Wilson, P.R. Blackett, et al., Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene J. Pediatr. Endocrinol. Metab. 23 (2010) 843-850.
150. Hawa N.S., Cockerill F.J., Vadher S., Hewison M., Rut A.R., Pike J.W., et al. Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping. Clin. Endocrinol. 1996, 45:85-92.
151. Katavetin P., Wacharasindhu S., Shotelersuk V. A girl with a novel splice site mutation in VDR supports the role of a ligand-independent VDR function on hair cycling. Horm. Res. 2006, 66:273-276.
152. Ma N.S., Malloy P.J., Pitukcheewanont P., Dreimane D., Geffner M.E., Feldman D. Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone 2009, 45:743-746.
153. Thompson E., Kristjansson K., Hughes M. Molecular scanning methods for mutation detection: application to the 1,25-dihydroxyvitamin D receptor 1991, Eighth workshop on Vitamin D, Paris, France, p 6.
154. Kanakamani J., Tomar N., Kaushal E., Tandon N., Goswami R. Presence of a deletion mutation (c.716delA) in the ligand binding domain of the vitamin D receptor in an Indian patient with vitamin D-dependent rickets type II. Calcif. Tissue Int. 2010, 86:33-41.
155. Rut A.R., Hewison M., Rowe P., Hughes M., Grant D., O'Riordan J.L.H. A novel mutation in the steroid binding region of the vitamin D receptor (VDR) gene in hereditary vitamin D resistant rickets (HVDRR). Vitamin D: gene regulation, structure-function analysis, and clinical application: eighth workshop on vitamin D 1991, 94-95. Walter de Gruyter, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
156. 3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol. Endocrinol. 1996, 10:1617-1631.
157. Malloy P.J., Eccleshall T.R., Gross C., Van Maldergem L., Bouillon R., Feldman D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J. Clin. Invest. 1997, 99:297-304.
158. Van Maldergem L., Bachy A., Feldman D., Bouillon R., Maassen J., Dreyer M., et al. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent müllerian ducts in a Turkish boy born to consanguineous parents. Am. J. Med. Genet. 1996, 64:506-513.
159. Magre J., Delepine M., Khallouf E., Gedde-Dahl T., Van Maldergem L., Sobel E., et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 2001, 28:365-370.
160. Nguyen T.M., Adiceam P., Kottler M.L., Guillozo H., Rizk-Rabin M., Brouillard F., et al. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D. J. Bone Miner. Res. 2002, 17:1728-1737.
161. Malloy P.J., Xu R., Peng L., Peleg S., Al-Ashwal A., Feldman D. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology 2004, 145:5106-5114.
162. Rochel N., Tocchini-Valentini G., Egea P.F., Juntunen K., Garnier J.M., Vihko P., et al. Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. Eur. J. Biochem. 2001, 268:971-979.
163. Rochel N., Hourai S., Moras D. Crystal structure of hereditary vitamin D-resistant rickets - associated mutant H305Q of vitamin D nuclear receptor bound to its natural ligand. J. Steroid Biochem. Mol. Biol. 2010, 121:84-87.
164. Macedo L.C., Soardi F.C., Ananias N., Belangero V.M., Rigatto S.Z., De-Mello M.P., et al. Mutations in the vitamin D receptor gene in four patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Arq. Bras. Endocrinol. Metabol. 2008, 52:1244-1251.
165. Malloy P.J., Zhu W., Zhao X.Y., Pehling G.B., Feldman D. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Mol. Genet. Metab. 2001, 73:138-148.
166. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 1996, 3:87-94.
167. Arita K., Nanda A., Wessagowit V., Akiyama M., Alsaleh Q.A., McGrath J.A. A novel mutation in the VDR gene in hereditary vitamin D-resistant rickets. Br. J. Dermatol. 2008, 158:168-171.
168. Zou J., Minasyan A., Keisala T., Zhang Y., Wang J.H., Lou Y.R., et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene. Audiol. Neurootol. 2008, 13:219-230.
169. Whitfield G.K., Hsieh J.C., Nakajima S., MacDonald P.N., Thompson P.D., Jurutka P.W., et al. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol. Endocrinol. 1995, 9:1166-1179.
170. Nguyen M., d'Alesio A., Pascussi J.M., Kumar R., Griffin M.D., Dong X., et al. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 2006, 21:886-894.
171. Zhou Y., Wang J., Malloy P.J., Dolezel Z., Feldman D. Compound heterozygous mutations in the vitamin D receptor in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia. J. Bone Miner. Res. 2009, 24:643-651.
172. Malloy P.J., Xu R., Cattani A., Reyes L., Feldman D. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J. Bone Miner. Res. 2004, 19:1018-1024.
173. Malloy P.J., Wang J., Peng L., Nayak S., Sisk J.M., Thompson C.C., et al. A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Arch. Biochem. Biophys. 2007, 460:285-292.
174. Schreiner C.A., Nagode L.A. Vitamin D-dependent rickets type 2 in a four-month-old cat. J. Am. Vet. Med. Assoc. 2003, 222:337-339.
175. Tanner E., Langley-Hobbs S.J. Vitamin D-dependent rickets type 2 with characteristic radiographic changes in a 4-month-old kitten. J. Feline. Med. Surg. 2005, 7:307-311.
176. Godfrey D.R., Anderson R.M., Barber P.J., Hewison M. Vitamin D-dependent rickets type II in a cat. J. Small Anim. Pract. 2005, 46:440-444.
177. LeVine D.N., Zhou Y., Ghiloni R.J., Fields E.L., Birkenheuer A.J., Gookin J.L., et al. Hereditary 1,25-dihydroxyvitamin D-resistant rickets in a Pomeranian dog caused by a novel mutation in the vitamin D receptor gene. J. Vet. Intern. Med. 2009, 23:1278-1283.
178. Hewison M., Rut A.R., Kristjansson K., Walker R.E., Dillon M.J., Hughes M.R., et al. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin. Endocrinol. 1993, 39:663-670.
179. Chen H., Hewison M., Hu B., Adams J.S. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc. Natl. Acad. Sci. USA 2003, 100:6109-6114.
180. Chrousos G.P., Renquist D., Brandon D., Eil C., Pugeat M., Vigersky R., et al. Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc. Natl. Acad. Sci. USA 1982, 79:2036-2040.
181. Chrousos G.P., Loriaux D.L., Brandon D., Shull J., Renquist D., Hogan W., et al. Adaptation of the mineralocorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the squirrel monkey. Endocrinology 1984, 115:25-32.
182. Chrousos G.P., Brandon D., Renquist D.M., Tomita M., Johnson E., Loriaux D.L., et al. Uterine estrogen and progesterone receptors in an estrogen- and progesterone- "resistant" primate. J. Clin. Endocrinol. Metab. 1984, 58:516-520.
183. 3 in dermal fibroblasts cultured from New World primates. Endocrinology 1985, 116:2523-2527.
184. Takahashi N., Suda S., Shinki T., Horiuchi N., Shiina Y., Tanioka Y., et al. The mechanism of end-organ resistance to 1 alpha,25-dihydroxycholecalciferol in the common marmoset. Biochem. J. 1985, 227:555-563.
185. Reynolds P.D., Ruan Y., Smith D.F., Scammell J.G. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J. Clin. Endocrinol. Metab. 1999, 84:663-669.
186. Giraldo A., Pino W., Garcia-Ramirez L.F., Pineda M., Iglesias A. Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children. Clin. Genet. 1995, 48:57-65.
187. Tsuchiya Y., Matsuo N., Cho H., Kumagai M., Yasaka A., Suda T., et al. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D. J. Clin. Endocrinol. Metab. 1980, 51:685-690.
188. Fujita T., Nomura M., Okajima S., Furuya H. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. J. Clin. Endocrinol. Metab. 1980, 50:927-931.
189. Kruse K., Feldmann E. Healing of rickets during vitamin D therapy despite defective vitamin D receptors in two siblings with vitamin D-dependent rickets type II. J. Pediatr. 1995, 126:145-148.
190. Balsan S., Garabedian M., Larchet M., Gorski A.M., Cournot G., Tau C., et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 1986, 77:1661-1667.
191. Weisman Y., Bab I., Gazit D., Spirer Z., Jaffe M., Hochberg Z. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am. J. Med. 1987, 83:984-990.
192. Hochberg Z., Tiosano D., Even L. Calcium therapy for calcitriol-resistant rickets. J. Pediatr. 1992, 121:803-808.
193. Weisman Y., Jaccard N., Legum C., Spirer Z., Yedwab G., Even L., et al. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues. J. Clin. Endocrinol. Metab. 1990, 71:937-943.
194. Ahmad W., Irvine A.D., Lam H., Buckley C., Bingham E.A., Panteleyev A.A., et al. A missense mutation in the zinc-finger domain of the human hairless gene underlies congenital atrichia in a family of Irish travellers. Am. J. Hum. Genet. 1998, 63:984-991.
195. Y. Weisman, P.J. Malloy, A.V. Krishnan, N. Jaccard, D. Feldman, Z. Hochberg Prenatal diagnosis of calcitriol resistant Rickets (CRR) by 1,25(OH)2D3 binding, 24-hydroxylase induction and RFLP analysis. Ninth workshop on Vitamin D, Orlando, 1994 p. 106.
196. 3. J. Biol. Chem. 2001, 276:29148-29156.
197. Swann S.L., Bergh J., Farach-Carson M.C., Ocasio C.A., Koh J.T. Structure-based design of selective agonists for a rickets-associated mutant of the vitamin d receptor. J. Am. Chem. Soc. 2002, 124:13795-13805.
198. Swann S.L., Bergh J.J., Farach-Carson M.C., Koh J.T. Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. Org. Lett. 2002, 4:3863-3866.
199. Kittaka A., Kurihara M., Peleg S., Suhara Y., Takayama H. 2Alpha-(3-hydroxypropyl)- and 2alpha-(3-hydroxypropoxy)-1alpha,25-dihydroxyvitamin D(3) accessible to vitamin D receptor mutant related to hereditary vitamin D-resistant rickets. Chem. Pharm. Bull. (Tokyo) 2003, 51:357-358.
200. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98:7498-7503.
201. Chen C.H., Sakai Y., Demay M.B. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology 2001, 142:5386-5389.
202. Li M., Chiba H., Warot X., Messaddeq N., Gerard C., Chambon P., et al. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001, 128:675-688.
203. Ahmad W., Faiyaz ul Haque M., Brancolini V., Tsou H.C., ul Haque S., Lam H., et al. Alopecia universalis associated with a mutation in the human hairless gene. Science 1998, 279:720-724.
204. Zlotogorski A., Hochberg Z., Mirmirani P., Metzker A., Ben-Amitai D., Martinez-Mir A., et al. Clinical and pathologic correlations in genetically distinct forms of atrichia. Arch. Dermatol. 2003, 139:1591-1596.
205. Cichon S., Anker M., Vogt I.R., Rohleder H., Putzstuck M., Hillmer A., et al. Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia. Hum. Mol. Genet. 1998, 7:1671-1679.
206. Hsieh J.C., Sisk J.M., Jurutka P.W., Haussler C.A., Slater S.A., Haussler M.R., et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J. Biol. Chem. 2003, 278:38665-38674.
207. Malloy P.J., Wang J., Jensen K., Feldman D. Modulation of vitamin d receptor activity by the corepressor hairless: differential effects of hairless isoforms. Endocrinology 2009, 150:4950-4957.
208. Wang J., Malloy P.J., Feldman D. Interactions of the vitamin D receptor with the corepressor hairless: analysis of hairless mutants in atrichia with papular lesions. J. Biol. Chem. 2007, 282:25231-25239.
209. Beaudoin G.M., Sisk J.M., Coulombe P.A., Thompson C.C. Hairless triggers reactivation of hair growth by promoting Wnt signaling. Proc. Natl. Acad. Sci. USA 2005, 102:14653-14658.
210. Thompson C.C., Sisk J.M., Beaudoin G.M. Hairless and Wnt signaling: allies in epithelial stem cell differentiation. Cell Cycle 2006, 5:1913-1917.
211. Wysolmerski J.J., Broadus A.E., Zhou J., Fuchs E., Milstone L.M., Philbrick W.M. Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proc. Natl. Acad. Sci. USA 1994, 91:1133-1137.
212. Cho Y.M., Woodard G.L., Dunbar M., Gocken T., Jimenez J.A., Foley J. Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: evidence for regulation at the anagen to catagen transition. J. Invest. Dermatol. 2003, 120:715-727.
213. Ikeda K., Lu C., Weir E.C., Mangin M., Broadus A.E. Transcriptional regulation of the parathyroid hormone-related peptide gene by glucocorticoids and vitamin D in a human C-cell line. J. Biol. Chem. 1989, 264:15743-15746.
214. Haussler M.R., McCain T.A. Basic and clinical concepts related to vitamin D metabolism and action. N. Engl. J. Med. 1977, 297:1041-1050.
215. DeLuca H.F. The vitamin D system in the regulation of calcium and phosphorus metabolism. Nutr. Rev. 1979, 37:161-193.
216. 3 receptor in target cells. Endocrinology 1988, 122:1224-1230.
217. 3 receptors and actions in prostate cancer cell lines. Endocrinology 1993, 132:1952-1960.
218. Underwood J.L., DeLuca H.F. Vitamin D is not directly necessary for bone growth and mineralization. Am. J. Physiol. 1984, 246:E493-498.
219. Miyamoto K., Kesterson R.A., Yamamoto H., Taketani Y., Nishiwaki E., Tatsumi S., et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 1997, 11:1165-1179.
220. Beer S., Tieder M., Kohelet D., Liberman O.A., Vure E., Bar-Joseph G., et al. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D. Clin. Endocrinol. (Oxf.) 1981, 14:395-402.
221. 3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. J. Clin. Endocrinol. Metab. 1984, 59:556-560.